Related Experiment Videos
Evaluation of two dextrose-based directly compressible excipients
Drug Development and Industrial Pharmacy
|January 7, 1999
Summary
Tablet excipient choice and manufacturing method significantly impact drug release and disintegration. Maltrin M510 excipient resulted in slower drug release compared to Emdex, especially when using wet granulation.
Area of Science:
- Pharmaceutical Sciences
- Materials Science
Background:
- Directly compressed excipients are crucial for efficient tablet manufacturing.
- Understanding excipient physical properties and compaction behavior is vital for formulation development.
Purpose of the Study:
- To evaluate the physical properties and compaction behavior of two dextrose-based directly compressed excipients: Emdex and Maltrin M510.
- To compare the effects of direct compression versus wet granulation on tablet properties and drug release.
Main Methods:
- Formulations containing anhydrous theophylline (drug model), Emdex or Maltrin M510 (diluents), and magnesium stearate (lubricant) were prepared.
- Tablets were manufactured using direct compression and wet granulation methods.
- Compacts were compressed at varying forces, and physical properties, disintegration time, and drug release were assessed.
Main Results:
- Wet granulation generally reduced mixture density and flow rate compared to solid-solid mixing.
- Tablet properties and mechanical strength varied significantly based on excipient type and manufacturing method.
- Maltrin M510 formulations exhibited longer disintegration times and slower drug release than Emdex formulations.
- Wet granulation of Maltrin M510 tablets suggested drug release was controlled by gel layer formation, not porosity.
Conclusions:
- Excipient selection and manufacturing process critically influence tablet performance and drug delivery.
- Comprehensive characterization of excipients is essential for consistent pharmaceutical product development.
- Different manufacturing processes for the same excipients can lead to significant variations in final drug product characteristics.